ArticleCurrent neurovascular research2026
Prognostic Factors for In-stent Restenosis After Cerebrovascular Stent Implantation among Ischemic Stroke Patients.
Article in Current neurovascular research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionIn-stent restenosis (ISR) critically impacts the efficacy of cerebrovascular stent implantation. We investigated the influence of clinical factors on the ISR.
methodsA total of 251 patients with ischemic stroke undergoing cerebrovascular stenting from November 2014 to March 2020 were recruited. The primary outcome was ISR within 12 months. Predictors were selected using the least absolute shrinkage and selection operator regression and logistic regression to build a nomogram. Model discriminative ability, calibration, and clinical utility were evaluated via the area under receiver operating characteristic curves (AUC), calibration plots, and decision curve analysis.
resultsMultivariate analysis identified coronary artery disease (OR, 3.35; 95% CI, 1.26-9.21; P=0.016), neutrophil-to-lymphocyte ratio (NLR, OR, 1.84; 95% CI, 1.50-2.37; P<0.001), and residual stenosis (OR, 1.08; 95% CI, 1.02-1.15; P=0.012) as independent risk factors for ISR. Hypertension, coronary artery disease, NLR, and residual stenosis were incorporated into the nomogram model. The model demonstrated an AUC of 0.862 (95% CI 0.783-0.929) upon internal validation. Subgroup analyses revealed no statistically significant heterogeneity stratified by age, gender, and stenosis location (all P≥0.1). DISCUSSION: Hypertension and NLR were potential predictive factors for in-stent restenosis after cerebrovascular stent implantation. In addition, patients with vertebral artery stenosis had a higher risk of in-stent restenosis than those with internal carotid artery stenosis.
conclusionCoronary artery disease, NLR, and residual stenosis were potential predictive factors for ISR after cerebrovascular stent implantation. The developed nomogram helps in identifying patients at high risk for ISR.
Indexed as
Identifiers
41832740What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.